Zeke Capital Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-1,048
Closed -$279K – 521
2022
Q1
$279K Buy
1,048
+228
+28% +$56K 0.01% 388
2021
Q4
$218K Sell
820
-212
-21% -$61.5K 0.01% 271
2021
Q3
$293K Hold
1,032
– – 0.02% 216
2021
Q2
$283K Sell
1,032
-689
-40% -$187K 0.02% 242
2021
Q1
$449K Buy
1,721
+154
+10% +$41.2K 0.03% 147
2020
Q4
$401K Buy
1,567
+177
+13% +$43.9K 0.03% 151
2020
Q3
$329K Hold
1,390
– – 0.04% 146
2020
Q2
$270K Buy
+1,390
New +$266K 0.05% 155
2018
Q3
– Sell
-2,779
Closed -$238K – 728
2018
Q2
$238K Hold
2,779
– – 0.02% 489
2018
Q1
$241K Buy
+2,779
New +$216K 0.02% 509

Other funds holding PODD

Zeke Capital Advisors's PODD Position: Q2 2022 in Review

Zeke Capital Advisors sold out of Insulet (PODD) in Q2 2022, closing a stake of 1,048 shares — an estimated $279K sold.

Zeke Capital Advisors first reported a position in PODD in Q1 2018 and held it in 10 quarters. The position peaked at $449K in Q1 2021. 450 funds tracked by Wall St. Rank hold PODD as of Q2 2022.

  • Zeke Capital Advisors reported no remaining Insulet position as of Q2 2022 after selling out during the quarter.
  • Zeke Capital Advisors sold 1,048 Insulet shares in Q2 2022, an estimated $279K.
  • Zeke Capital Advisors first reported a position in Insulet in Q1 2018 and held it in 10 quarters.
  • Zeke Capital Advisors's Insulet position peaked at $449K in Q1 2021.
  • 450 funds tracked by Wall St. Rank held Insulet as of Q2 2022.

Based on Zeke Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.